Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

Thiam, Laty G.; McHugh, Kirsty; Ba, Aboubacar; Li, Rebecca; Guo, Yicheng; Pouye, Mariama N.; Cisse, Awa; Pipini, Dimitra; Diallo, Fatoumata; Sene, Seynabou D.; Patel, Saurabh D.; Thiam, Alassane; Sadio, Bacary D.; Mbengue, Alassane; Vigan-Womas, Inés; Sheng, Zizhang; Shapiro, Lawrence; Draper, Simon J.; Bei, Amy K.

doi:10.1038/s41541-024-00986-x

npj Vaccines

2024

DOI: 10.1038/s41541-024-00986-x

|View full text |Cite

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

Laty G. Thiam,

Kirsty McHugh,

Aboubacar Ba

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children

Natama,

Salkeld,

Somé

et al. 2024

The Lancet Infectious Diseases

View full text Add to dashboard Cite

Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children

Natama,

Salkeld,

Somé

et al. 2024

The Lancet Infectious Diseases

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

Cited by 1 publication

References 45 publications

Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children

Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children

Contact Info

Product

Resources

About